ADVFN Logo
Registration Strip Icon for monitor Customized watchlists with full streaming quotes from leading exchanges, such as NASDAQ, NYSE, AMEX, OTC Markets Small-Cap, LSE and more.
Anavex Life Sciences Corporation

Anavex Life Sciences Corporation (AVXL)

6.58
0.67
(11.34%)
At close: July 23 4:00PM
6.45
-0.13
( -1.98% )
After Hours: 4:07PM

Professional-Grade Tools, for Individual Investors.

AVXL News

Official News Only

AVXL Discussion

View Posts
georgejjl georgejjl 4 minutes ago
Extremely bullish per Stocktwits

https://stocktwits.com/symbol/AVXL/sentiment

Good luck and GOD bless,
👍️0
xodcode xodcode 6 minutes ago
Speaking of $10, any concrete positive news, possibly delivered in the upcoming presentations, might well close that Jan 1 $7 to $10 gap as rapidly as it was created. Liking the recent AVXL action!

WGT!
👍️ 1
k9uwa k9uwa 13 minutes ago
We closed at $6.58. Volume at 3:59:50 was 2,134,269 At 4PM MOC orders were filled volume jumped to 2,157,400. Undoubtedly the Institutions bought a good share of today's 2+m shares. Not a clue where we will be end of Friday. Presentations could have some effect, Institutions wanting more shares could have an effect. Silly Shorts buying their way out of their positions could have some effect. by 4:20PM 2,171,374 shares sold/bought. Hope you didn't get wet. OR worse forget to shut down and get real salty. 🏁🏁🏁 we are within sight of the checkered flag. Wild guess on my part into 2025 a bit.

John k9uwa
👍️0
longtermbeliever longtermbeliever 24 minutes ago
the best have yet to come.JUST HOLD ON TIGHT LOOOOOOOOOOOOOOOOOOOOOOOOOOOOOOOOOOOOOOOOOOOOOOOOOOOONGS
🆖 1 🍼 1 🏁 1 👍️ 2
RedShoulder RedShoulder 26 minutes ago
AVXL close: 6.58 +0.67 (+11.34%)

Another gain leading to the annual Alzheimer conference, where Anavex will have several presentations.

IMO, the run up will continue into next week.

I think we are getting attention from new eyes based on this recent run.
🆖 1 🏁 1 👍️ 2 💩 1
tredenwater2 tredenwater2 52 minutes ago
Im not getting exciting until we close above $10 to break this downward trend. All fake trading as institutional accumulation continues. Reverse psychology trading trying to break or discourage dug in retail longs.

I might add that until we do break this down ward trend with a close above $10 we have a chance to drop further regardless of the 4-5 upcoming presentations. False sense of security being floated along with false prophetic price and trading volume.

All in my humble opinion of course.
🏁 1 👍️ 4
georgejjl georgejjl 54 minutes ago
Part A of the phase 2 Anavex 3-71 schizophrenia trial has been completed. I believe that Part B of the phase 2 Anavex 3-71 schizophrenia trial will be completed before the end of summer 2024.

https://classic.clinicaltrials.gov/ct2/show/NCT06245213

Good luck and GOD bless,
🆖 1 👍️ 2 💩 1
georgejjl georgejjl 60 minutes ago
Coming presentations by Anavex

26 July 2024 three presentations concerning Anavex at the Fragile X conference

27 July 2024 one presentation regarding Anavex at the Fragile X conference

28 July 2024 one presentation concerning Anavex at the Alzheimer’s disease conference

29 July 2024 one presentation concerning Anavex at the Alzheimer’s disease conference

6 presentations in total

Good luck and GOD bless,
🆖 1 👍️ 3 💩 1
tradeherpete tradeherpete 1 hour ago
We'll be lucky if the EMA sees the opportunity here to help its health care system. And so will they.


pete [quote: These unsolicited studies crediting Anavex with advances in Science are very positive signs of good things to come.]

we are involved in an evolutionary learning process, like it or not. My advice is to roll w/it, the learning process is building on itself, not a trial and error roll out at this point, we should know better.

I think most of us agree that we have now looked- recognize a glimpse of what is next. Clearly the CNS (makeup and functional works) is little more than a blank piece of paper to us as wee sit here. At least we are recognizing a little more of , "what we know, we do not know", and that is a good start.

We would all like to see-recognize some giant leap from here but that may take a long time or AVXL might present a brilliant flash of new insight. We must keep walking the perimeter else what we think we know gets lost . Being human comes w/responsibilities and obligations....I guess.
🆖 1 💩 1
tradeherpete tradeherpete 1 hour ago
Trading seems to be counter intuitive, when it's at a high PPS you admire it and just want to see it appreciate, then...

Well, you know what happens then.

It doesn't matter how many times you get fooled the feeling stays the same.

That's the day you become an investor, if you have any money left.
👍️ 3 💩 1 🦨 1
Steady_T Steady_T 1 hour ago
I think you are incorrect on the way that timeline works.
🆖 1 💩 1
abew4me abew4me 1 hour ago
Well done, sir. I hope you recoup all of your losses...and then some!
🏁 1 👍️ 3
RedShoulder RedShoulder 2 hours ago
Here we go back up, now 6.59 +0.68 (+11.59%)
A good start for the power hour.
🏁 1 👍️ 2
georgejjl georgejjl 2 hours ago
It appears that AVXL stock price should close at of very near the high of the day with exceptionally high buying volume.

Good luck and GOD bless,
🆖 1 👍️ 1 💩 1
xodcode xodcode 2 hours ago
"I won't be surprised if this closes flat or or in the red."

The only red at the close will be your face!

WGT!
🏁 1 👍️ 4
kund kund 2 hours ago
I won't be surprised if this closes flat or or in the red.
💩 1 🦨 1
Mr.Fields Mr.Fields 3 hours ago
More trading activity and a strong rise in price are expected to fill a gap that's clearly visible on the chart. If we go above $7, some doubters and market influencers might try to prevent further gains.
👍️0
poguemahone poguemahone 3 hours ago
Love is the Seventh Wave.
👍️0
Talon38 Talon38 4 hours ago
Cres...thank you for "rethinking" my logic!
👍️ 1
crescentmotor crescentmotor 4 hours ago
Good news is that with the recent low prices I was able to increase holdings...

I did the same with both AVXL stock and options.
👍️ 3
crescentmotor crescentmotor 4 hours ago
It's crazy to have Anavex with lower MC.

I agree but, with no visible progress toward FDA approval in the U.S., there is no way for AVXL's stock to currently approach what we believe is a fair valuation. Further progress toward approval in Europe would change the dynamics.

In light of the DOJ investigation into Dr. Wang and the developments surrounding Remi Barbier (Chairman and CEO) and his wife, Lindsay Burns (SVP-Neuroscience), I reduced by financial exposure at SAVA by selling my stock position resulting in, for me, a huge realized loss. In order to stay in the SAVA game with some hope of recouping my losses pending RETHINK Phase III results expected before year end 2024, I increased my position in cheaper June 2025 call options. My due diligence is that the current legal controversy should have no effect on SAVA's ongoing Phase III trials but uncertainty remains so I took some cash off the table. If the RETHINK trial is successful, I will still be amply rewarded.
🆖 1 👍️ 3 👎️ 1 💩 1 🤣 1
sab63090 sab63090 4 hours ago
Maybe a few of you have noticed this:

$AVXL has shown good action, $ANVS is slanting currently lower, and $SAVA came off a double bottom at around $9 and just formed a double TOP at or near current prices....good to see that AVXL is enjoying the spotlight currently
👍️ 3 🤯 1
georgejjl georgejjl 5 hours ago
Institutions are helping the upward price move for AVXL stock. The financial institutions have been and are continuing to buy AVXL today.

Good luck and GOD bless,
🆖 1 👍️ 3 💩 1
sab63090 sab63090 5 hours ago
Good luck, volume plus a strong price push should work towards that "gap hole" which is very visible on the chart.should we go beyond $7 or so...the naysayers will do their best to stop it with the mm's helping.....let's hope they capitulate and really do the push part! Could be exciting, but I temper my feelings with the realization that I have been smacked hard so many times....lol
👍️ 1
LakeshoreLeo1953 LakeshoreLeo1953 5 hours ago
Lunch stop outside West Point.
Friend grew up on old JP Morgan property here.
Yea, if I hadn’t been speaking with friend outside Boston about AVXL I would not have caught the momentum play.
Retrospect…Those with more “juice” than I ran it to 5.50 and caught me.
Sidebar: Single lot fill!!!! I was surprised (5.62).
Gotta blaze to Cape May before rain.
What do you think?
7.78 within reach?
By Friday?
👍️ 1 💩 2 🦨 2
ignatiusrielly35 ignatiusrielly35 5 hours ago
Likely there are some retail shorts getting margin calls by now.
🏁 1 👍️ 7
georgejjl georgejjl 5 hours ago
AVXL up $0.76 so far today!!!

Good luck and GOD bless,
🆖 1 👍️ 3 💩 1
RedShoulder RedShoulder 5 hours ago
Vol over Million shares now.
🏁 1 👍️ 4
tschussmann1 tschussmann1 6 hours ago
Well...it was quite a pleasant experience...and now I am thinking it could actually happen. Good news is that with the recent low prices I was able to increase holdings...
👍️ 4
k9uwa k9uwa 6 hours ago
Seems this will be the high volume day you were looking for. YES 700K traded in the first hour today. 🏁🏁🏁 yes the "Checkered Flag" is within sight. Bet Leo will be happy he is IN rather than OUT.

John k9uwa
🏁 1 👍️ 6 💥 1
mike_dotcom mike_dotcom 6 hours ago
Keep talking little man, you're doing a great job!
👍️ 3 💥 1
tschussmann1 tschussmann1 6 hours ago
Seems this will be the high volume day you were looking for...picked up a few more today. 🙂
👍️ 1
sab63090 sab63090 6 hours ago
You are witnessing the 5th Wave up right now and there are 2 important developments, one the fact that the 200 day on the daily was broken to the upside and back tested successfully, the other thing is that the all important WEEKLY chart shows that the ONE-YEAR downtrend has been broken....naturally, a push up past highest resistance @ around $7 points to that very BIG GAP which suggests a move towards $9.50 or so.
🏁 2 👍️ 5
georgejjl georgejjl 6 hours ago
SHORT SQUEEZE coming soon for AVXL stock!!!

Good luck and GOD bless,
🆖 1 💩 1
georgejjl georgejjl 6 hours ago
AVXL up $0.53 so far today!!!

Good luck and GOD bless,
🆖 1 👍️ 2 💩 1
WilliamMunny WilliamMunny 7 hours ago
Boi, I agree that there has been an upward move since the rebalancing overhang was removed, a rotation into small cap stocks began, and the XBI, in particular, started to rebound. However, there is no denying that the EF Hutton report has been an accelerant. The medium is the message.
🆖 1 🍼 1 🏁 2 👍️ 9 💥 1
boi568 boi568 7 hours ago
I doubt that's the explanation. This appears to be the continuation of an upward move that predates the latest stock target.
🏁 1 👍️ 2
ignatiusrielly35 ignatiusrielly35 7 hours ago
Good volume too. I wonder if EF Hutton is putting clients into the stock.
🎯 1 🏁 1 👍️ 5
nidan7500 nidan7500 7 hours ago
Anavex Life Sciences Corp. (AVXL)

Following
Compare
6.24
+0.34
(+5.67%)
As of 9:46 AM EDT. Market Open.

Will today be THE Start DAY we have worked for?
🎯 1 🏁 1 👍️ 3
frrol frrol 7 hours ago
Rapporteurs are assigned by the CHMP within 7 months of our intended MAA submission date. We gave that date to the EMA via an LOI and/or "eligibility request".
🏁 1 👍️ 3
georgejjl georgejjl 7 hours ago
AVXL up $0.32 that is a good start for today

Good luck and GOD bless,
🆖 1 👍️ 2 💩 1
WilliamMunny WilliamMunny 7 hours ago
New brokerage firm. New audience. The medium is the message.
🏁 1 👍️ 3
georgejjl georgejjl 7 hours ago
Coming presentations by Anavex

26 July 2024 three presentations concerning Anavex at the Fragile X conference

27 July 2024 one presentation regarding Anavex at the Fragile X conference

28 July 2024 one presentation concerning Anavex at the Alzheimer’s disease conference

29 July 2024 one presentation concerning Anavex at the Alzheimer’s disease conference

6 presentations in total

Good luck and GOD bless,
🆖 1 🍼 1 🏁 2 👍️ 7
kund kund 7 hours ago
AAIC no show this year...typical Misleading
💩 3 🖕 1 🤮 1 🦨 3
Hoskuld Hoskuld 9 hours ago
MAA would typically be submitted 7 months after rapporteurs are assigned. That would put filing date in September.
🏁 2 👍️ 9 💥 1
Hoskuld Hoskuld 9 hours ago
other than for an end point the FDA now say isn't required because it's too hard to show.

Actually, I believe Anavex has said that they deliberately used the odds ratio for that reason. They have never wavered in that, that I know of. The company is steadfast in saying that it hit all its endpoints. My understanding is that the odds ratio was in their statistical analysis plan. Do you have a link to something that I might have missed that says otherwise?
🆖 1 🍼 1 🏁 1 👍️ 6
nidan7500 nidan7500 9 hours ago
pete [quote: These unsolicited studies crediting Anavex with advances in Science are very positive signs of good things to come.] we are involved in an evolutionary learning process, like it or not. My advice is to roll w/it, the learning process is building on itself, not a trial and error roll out at this point, we should know better.

I think most of us agree that we have now looked- recognize a glimpse of what is next. Clearly the CNS (makeup and functional works) is little more than a blank piece of paper to us as wee sit here. At least we are recognizing a little more of , "what we know, we do not know", and that is a good start.

We would all like to see-recognize some giant leap from here but that may take a long time or AVXL might present a brilliant flash of new insight. We must keep walking the perimeter else what we think we know gets lost . Being human comes w/responsibilities and obligations....I guess.
🏁 1 👍️ 7
Hosai Hosai 10 hours ago
We already have the results for AVXL, they were strong other than for an end point the FDA now say isn't required because it's too hard to show.
So what's the point in taking a chance that SAVA has good results (especially when their early stage results have been called into question which is what had caused people to be bullish on their current trials) when we already have the results from Anavex so not having to take such a chance. It's crazy to have Anavex with lower MC.
🆖 1 🍼 1 🏁 2 👍️ 9 💥 4
Investor2014 Investor2014 12 hours ago
The SEC definition is at odds with clinical trial outcome statistics.

“Trial success is not material because that is the presumed outcome. Most companies would PR a trial success since that is a positive piece of news.”

If the SEC was right about their definition it would be really easy to be a biotech investor and the returns would be poor.

Missling, who some believe is truthful, has stated several times that an MAA filing will PR’ed as indeed pretty much all companies would.
🏁 1 🐀 1 👍️ 1 🖕 1 🤮 1
Steady_T Steady_T 13 hours ago
My opinion on that is filing an MAA is not material. It has no immediate financial consequences. The results of an MAA filing would be considered material.
The SEC has said that a trial failure is a material event because of the loss of the investment in drug development and the trials.
Trial success is not material because that is the presumed outcome. Most companies would PR a trial success since that is a positive piece of news.

Additionally, in the course of its discussion of materiality in the Reg. FD adopting release, the Commission also provided a non-exhaustive list of information and events that are likely to be considered material, including:
• earnings information;
• mergers, acquisitions, joint ventures or tender offers;
• acquisitions or dispositions of company assets;
• new products or discoveries;
• developments regarding customers or suppliers (such as the acquisition or loss of a contract);
• changes in control or management;
• changes in a company’s auditors or receipt of notice that the company may no longer rely on an audit report;
• events regarding a company’s securities, such as:
o defaults on senior securities;
o a call of securities for redemption;
o repurchase plans;
o stock splits or changes in dividends;
o changes to the rights of shareholders;
o the public or private sale of securities; and
• bankruptcies and receiverships.
Other Examples of Materiality
Other examples of information or events that may be considered material include:
• significant litigation or governmental investigations, whether pending or threatened;
• regulatory approvals or changes in regulations;
• changes in executive compensation;
• changes to a company’s credit rating;
• labor disputes or negotiations;
• significant product defects, recalls or returns;
• significant pricing changes; and
• potential proxy contestsMateriality as Defined by the U.S. Supreme Court
In TSC Industries, Inc., the U.S. Supreme Court establishes that information is material:
• “if there is a substantial likelihood that a reasonable shareholder would consider it important in deciding …” whether to take some action with respect to a company’s securities, such as how to vote in response to a proxy solicitation or whether to buy, sell or hold the securities; or
• if it “would have been viewed by the reasonable investor as having significantly altered the ‘total mix’ of information made available.”
In Basic, Inc., the Court revisited the definition of materiality in the context of information and events that are contingent or speculative. Rejecting a “bright-line” test in favor of a more flexible standard that requires the exercise of judgment in light of the facts and circumstances, the Court held that determining whether a contingent or speculative event is material requires “a balancing of both the indicated probability that the event will occur and the anticipated magnitude of the event in light of the totality of the company activity.” Meaning that if the event in question has not yet happened, and it remains unclear as to whether it may happen at all, then determining whether it is material will require assessing the surrounding circumstances and weighing the probability of the event actually occurring against its significance to the company as a whole.
🆖 1 🍼 1 🏁 1 👍️ 3

Your Recent History

Delayed Upgrade Clock